The clinical application of antibodies in the diagnosis and staging of human cancer has been widely investigated. In breast cancer, oligoclonal antisera to Epithelial Membrane Antigen (EMA) (Heyderman et al., 1979) and anti human mammary epithelial antigens (HME Ags) (Ceriani et al., 1977) have been raised against the delipidated milk fat globule membrane (MFGM), and have been used in the early detection and diagnosis of cancer. Sloane et al., 1980 Dearnaley et al., 1981; Ceriani et al., 1982) .
A more widespread application could be achieved by using monoclonal antibodies with a greater specificity for one antigenic epitope. Recently, the monoclonal antibodies HMFGI and HMFG2 have been raised against the delipidated MFGM (TaylorPapadimitriou et al., 1981) . These react against different antigenic epitopes present on the same molecule to which EMA antibodies are directed (Ormerod et al., 1983) . The immunohistochemical staining patterns of both oligoclonal antibodies and monoclonal antibodies to MFGM are extracellular in the ducts and tubules of normal and benign breast tissue and markedly heterogenous in malignant breast tissue (Valagussa et al., 1978 ), Bloom's grade (Bloom & Richardson, 1957) and oestrogen receptor status (Cooke et al., 1979 (Cardiff) using the dextran charcoal method (Cooke et al., 1979) . The presence of absence of metastatic spread of the primary tumour to the axillary lymph node was known for 89 of the patients with carcinoma. The Bloom's grade for each case was determined independently from the routine H & E stained sections.
The benign cases comprised the following: fibroadenosis (16), fibroadenoma (11), lipoma (2), papilloma (3), gynaecomastia (2), cyst (1), and duct ectasia (1). The carcinomas were of the following types: infiltrating ductal (67), lobular (5), mixed ductal and lobular (3), medullary (3), infiltrating comedocarcinoma (4), infiltrating cribriform (3), mucoid (3), tunular (2), mixed medullary and lobular (1) and carcinoid (2).
In each case the tissue was fixed in 10% neutral buffered formol saline for -24-48h, taken through alcohols and chloroform to paraffin wax on an automatic processor, and embedded in paraffin wax.
Staining of sections
Sections (4pm) were cut from each block of tissue.
Endogenous peroxidase activity was inhibited using 0.5% H202 in methanol for 10 min. The sections were digested using 0.1% trypsin in 0.1% calcium chloride solution at 37°C for 10min (Mepham et al., 1979) . In 10 cases control sections were not digested in trypsin. The sections were stained using an indirect immunoperoxidase assay (Burns, 1978 (Nie et al., 1981) . Pairwise comparison of the curves was 
Results

Controls
A comparison of the immunohistochemical staining pattern in undigested and trypsin digested tissue sections showed that trypsin digestion gave greater staining intensity and reduced background staining without affecting the distribution of the stain. Of the 20 cases where 2 consecutive sections were stained on separate occasions, the staining pattern was reproducible, although the overall intensity of staining in the sections often differed.
Normal and benign tissue The staining pattern of histologically normal and benign tissue with both HMFG1 and HMFG2 was located on the luminal surface of cells lining and secreted material within the ducts and tubules. (Figure 1 & Figure 2 ). Staining of benign tissue was generally greater than in normal tissue and varied in extent and intensity both between histological types of cases and between cases. No intracellular staining was observed except in some benign cases where weak intracellular staining was occasionally observed in the apical region of cells lining ducts and tubules which contained secretion. Figure  9 . Although there appeared to be some differences between the curves, particularly with HMFG2, statistical analysis of the 3 curves showed that there was no significant difference in the survival of each staining group in sections stained with either HMFG1 or HMFG2 (P=0.79; P=0.18).
Discussion
The immunohistochemical staining patterns of the monoclonal antibodies HMFG1 and HMFG2 in breast tissue have been described previously . The patterns observed in this study are similar, that is, extracellular in the ducts and tubules of normal and benign tissue and variable in malignant tissue. The heterogeneity of staining in malignant breast tissue was apparent both in the extent of intracellular staining and in the relative intensity of staining. In some cases extracellular staining was observed both in tubules and between cells. Staining of the intracytoplasmic vacuoles was also considered extracellular, as electron microscopy has shown that the surface of the inner membrane of the vacuole has features typical of the exterior surface of the cell membranes (Battifora, 1975 (Brandtzaeg & Rognum, 1982) . The change in the immunohistochemical staining pattern from extracellular in normal and benign breast tissue to mixed with varying amounts of intracellular positivity in malignant breast tissue has been observed using other antibodies Foster et al., 1982) and lectins (Franklin, 1983) .
The staining grades were designed to reflect the immunohistochemical staining patterns observed, whilst being in a form which could be related to indices of prognosis and to survival. Since the staining pattern in normal, benign and structurally differentiated tumours (those with extensive tubule formation) was extracellular, and became more intracellular as structural differentiation was lost, the grading system took into account the relative intensity of extracellular and intracellular staining and also the number of cells with intracellular staining. The 20 control sections where 2 consecutive sections were stained on separate occasions showed the same staining pattern on both sections but the overall intensity of stain throughout the section varied. Little emphasis, therefore, was placed on the overall intensity of the stain. Heterogeneity was observed between different areas of a tissue section and was a limitation of the grading system, for one area of tissue with a less predominant staining pattern, and therefore not graded, might influence the survival of the patient unnoticed. This heterogeneity also made grading difficult in many cases, but when the sections were graded on 2 separate occasions 84% reproducibility was obtained. This method of grading the stains contrasts with that used in another study relating the immunohistochemical staining of HMFG1 to survival and to indices of prognosis (Wilkinson et al., 1984) , where the grading was based on the uniformity, extent and the overall intensity of the stain.
There was no significant correlation when the staining grades were related to indices of prognosis and relapse-free survival. A significant correlation might have been expected when relating the staining grades to Bloom's grade since tumours with There was no association of the staining grades with oestrogen receptor status. In addition no correlation of the staining grades with involvement of axillary lymph nodes was observed. There was, however, a trend, in that a Grade A staining pattern with both HMFG1 and HMFG2 was more frequently seen in patients without lymph node involvement.
For HMFG1 and HMFG2 to be useful in determining the prognosis of breast cancer patients, the different staining patterns observed should be either closely correlated to existing prognostic indicators or be clearly related to survival, even in a relatively small series of cases. Relating the relapsefree survival of 34 patients to the staining grade, although there appeared to be some difference between the survival curves of the 3 staining grades, statistical comparison of the curves showed that they were not significantly different when either HMFG1 or HMFG2 was used. The antibodies are therefore of little use in routine diagnosis. Similar results were obtained by Wilkinson et al. (1984) where there was no significant association of the staining patterns observed to indices of prognosis such as Bloom's grade, the presence of metastases in the axillary nodes and the oestrogen receptor status. However, these authors identified a group of patients whose tumours did not stain with HMFG1 and who had a particularly poor prognosis. High levels of extracellular staining were considered indicators of a good prognosis. Although the immunoperoxidase staining technique was different in some respects to the one used in this study, a comparison of the staining patterns observed using the 2 techniques in 10 cases showed agreement. The different results must therefore be either due to the different method of grading used or, in the case of those patients with negatively stained tumours, the small number of cases.
The results of this study show that with present methods available for grading staining patterns the immunohistochemical staining patterns of HMFG1 and HMFG2 in malignant breast tissue do not help in determining the overall prognosis in an indivudual patient.
